Tejara Capital Ltd’s Heron Therapeutics Inc Position
Does Tejara Capital Ltd own Heron Therapeutics Inc (AXD2)? Yes — 6.34M shares worth $5M (+1.67% of its 13F portfolio) as of Q1 2026, up from 5.13M shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
6.34M
% of Portfolio
+1.67%
Quarters Held
14
currently held
Position History AXD2
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 6.34M | $5M | +1.67% |
| Q4 2025 | 5.13M | $7M | +1.57% |
| Q3 2025 | 4.59M | $6M | +3.02% |
| Q2 2025 | 4.52M | $9M | +4.34% |
| Q1 2025 | 4.58M | $10M | +3.89% |
| Q4 2024 | 4.66M | $7M | +4.67% |
| Q3 2024 | 5.31M | $11M | +5.03% |
| Q2 2024 | 4.19M | $15M | +5.33% |
| Q1 2024 | 4.41M | $12M | +4.49% |
| Q4 2023 | 5.28M | $9M | +3.76% |
| Q3 2023 | 2.11M | $2M | +1.23% |
| Q2 2023 | 1.64M | $2M | +0.94% |
| Q1 2023 | 1.67M | $3M | +1.29% |
| Q4 2022 | 493.6K | $1M | +0.71% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tejara Capital Ltd’s full portfolio or all institutional holders of AXD2.